Target organ damage in a population at intermediate cardiovascular risk, with adjunctive major risk factors: CArdiovascular PREvention Sacco Study (CAPRESS)

Internal and Emergency Medicine

Volumn 6, Issue 4, 2011, Pages 337-347

  Perego, Francesca ^a   Renesto, Elio ^a   Arquati, Massimo ^a   Scandiani, Luciana ^a   Cogliati, Chiara ^a   Torzillo, Daniela ^a   Zocchi, Luca ^a   Casazza, Giovanni ^b   Duca, Piergiorgio ^a   Chirchiglia, Saverio ^c   Lacaita, Gemma ^c   Panteghini, Mauro ^a   Cortellaro, Michele ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Local Health Unit of Milan   (Italy)

Author keywords

Algorithms; Carotid artery diseases; Diagnosis; Diagnostic techniques cardiovascular disease; Hypertension; Prevention and control; Prognosis; Risk factors

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CAROTID ARTERY DISEASE; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; HEALTH SURVEY; HUMAN; ITALY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PREVALENCE; RISK; RISK FACTOR; STATISTICAL MODEL; SYSTOLE;

ADULT; AGED; ALGORITHMS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; HEALTH STATUS INDICATORS; HUMANS; ITALY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; RISK FACTORS; SYSTOLE;

EID: 79960562114     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-010-0501-7     Document Type: Article

References (39)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367: 1747-1757.
2. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P (1999) Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 353: 1547-1557.
3. Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ et al (2003) Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 290: 898-904.
4. Smith SC Jr, Greenland P, Grundy SM (2000) Prevention conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention. Executive summary. Circulation 101: 111-116.
5. Greenland P, Smith SC Jr, Grundy SM (2001) Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. Circulation 104: 1863-1867.
6. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) (2001) JAMA 285: 2486-2497.
7. Palmieri L, Panico S, Vanuzzo D, Ferrario M, Pilotto L, Sega R et al (2004) Evaluation of the global cardiovascular absolute risk: the Progetto CUORE individual score. Ann Ist Super Sanita. 40: 393-399.
8. Assmann G, Cullen P, Schulte H (2002) Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 105: 310-315.
9. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De BG et al (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24: 987-1003.
10. Collins GS, Altman DG (2009) An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study. BMJ 339: b2584.
11. Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J (1961) Factors of risk in the development of coronary heart disease-six years follow-up experience: the Framingham Study Ann Intern Med 55: 33-50.
12. Michos ED, Vasamreddy CR, Becker DM, Yanek LR, Moy TF, Fishman EK et al (2005) Women with a low Framingham risk score and a family history of premature coronary heart disease have a high prevalence of subclinical coronary atherosclerosis. Am Heart J 150: 1276-1281.
13. Ridker PM, Buring JE, Rifai N, Cook NR (2007) Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 297: 611-619.
14. Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP et al (2002) AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 106: 388-391.
15. Fiscella K, Tancredi D, Franks P (2009) Adding socioeconomic status to Framingham scoring to reduce disparities in coronary risk assessment. Am Heart J 157: 988-994.
16. Mancia G, De BG, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. (2007) 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur Heart J 2007 28: 1462-1536.
17. Law MR, Morris JK, Wald NJ (2009) Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 338: b1665.
18. Greving JP, Buskens E, Koffijberg H, Algra A (2008) Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk. Circulation. 117: 2875-2883.
19. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ et al (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359: 2195-2207.
20. Lloyd-Jones DM (2010) Cardiovascular risk prediction: basic concepts, current status and future directions. Circulation 121: 1768-1777.
21. Desai MY, Nasir K, Braunstein JB, Rumberger JA, Post WS, Budoff MJ et al (2004) Underlying risk factors incrementally add to the standard risk estimate in detecting subclinical atherosclerosis in low- and intermediate-risk middle-aged asymptomatic individuals. Am Heart J 148: 871-877.
22. Ambrosetti M, Pedretti RF (2008) Does metabolic syndrome predict silent carotid stenosis in coronary patients? Intern Emerg Med 3: 81-82.
23. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F et al (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364: 937-952.
24. Scott IA (2009) Evaluating cardiovascular risk assessment for asymptomatic people. BMJ 338: a2844.
25. Baldassarre D, Porta B, Camera M, Amato M, Arquati M, Brusoni B et al (2009) Markers of inflammation thrombosis and endothelial activation correlate with carotid IMT regression in stable coronary disease after atorvastatin treatment. Nutr Metab Cardiovasc Dis 19: 481-490.
26. Arnlov J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D et al (2005) Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 112: 969-975.
27. Ankle Brachial Index Collaboration (2008) Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis. JAMA 300: 197-208.
28. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M (2007) Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115: 459-467.
29. Sehestedt T, Jeppesen J, Hansen TW, Rasmussen S, Wachtell K, Ibsen H et al (2009) Which markers of subclinical organ damage to measure in individuals with high normal blood pressure? J Hypertens 27: 1165-1171.
30. Ingelsson E, Sullivan LM, Fox CS, Murabito JM, Benjamin EJ, Polak JF et al (2007) Burden and prognostic importance of subclinical cardiovascular disease in overweight and obese individuals. Circulation 116: 375-384.
31. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL et al (2006) ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)-summary of recommendations. J Vasc Interv Radiol 17: 1383-1397.
32. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18: 1440-1463.
33. Prati P, Vanuzzo D, Casaroli M, Di CA, De BF, Feruglio GA et al (1992) Prevalence and determinants of carotid atherosclerosis in a general population. Stroke 23: 1705-1711.
34. Arnlov J, Ingelsson E, Sundstrom J, Lind L (2010) Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 121: 230-236.
35. Gottdiener JS, Reda DJ, Materson BJ, Massie BM, Notargiacomo A, Hamburger RJ et al (1994) Importance of obesity, race and age to the cardiac structural and functional effects of hypertension. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. J Am CollCardiol 24: 1492-1498.
36. Simon A, Megnien JL, Chironi G (2010) The value of carotid intima-media thickness for predicting cardiovascular risk. Arterioscler Thromb Vasc Biol 30: 182-185.
37. Cournot M, Taraszkiewicz D, Cambou JP, Galinier M, Boccalon H, Hanaire-Broutin H et al (2009) Additional prognostic value of physical examination, exercise testing and arterial ultrasonography for coronary risk assessment in primary prevention. Am Heart J 158: 845-851.
38. Redberg RF, Benjamin EJ, Bittner V, Braun LT, Goff DC Jr, Havas S et al (2009) ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on performance measures (writing committee to develop performance measures for primary prevention of cardiovascular disease): developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research. Circulation 120: 1296-1336.
39. Sciarretta S, Valenti V, Tocci G, Pontremoli R, Rosei EA, Ambrosioni E et al (2010) Association of renal damage with cardiovascular diseases is independent of individual cardiovascular risk profile in hypertension: data from the Italy-developing Education and awareness on MicroAlbuminuria in patients with hypertensive. Disease study J Hypertens 28: 251-258.